Clinical Research Directory

Inclusion criteria: * Patients with localized breast cancer having completed primary therapy (operation +/- chemotherapy +/- radiotherapy) in the last 6 months - Distress Thermometer ≥ 5 - Age ≥ 18 years - Signed informed consent for participation of the trial * Prior cancer is allowed * Prior treatment - including chemotherapy - for a prior malignant tumor (including breast cancer) is allowed * Concomitant participation in an experimental therapeutic drug trial is allowed * Ongoing or planned Anti-her2/neu, immune checkpoint inhibitor, antihormonal and CDK4/6 inhibitor therapy or other adjuvant treatment scheduled for \> 3 months during study period is allowed * Use of other complementary methods (including mistletoe) is allowed. Exclusion criteria: * Patients with language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study * Severe physical or psychiatric comorbidity that prevents a patient from participating in the study * Patients incapable of giving consent * Pregnancy